Literature DB >> 18848758

Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.

Hua Shen1, Wen Gao, Yu-jie Wu, Hai-rong Qiu, Yong-qian Shu.   

Abstract

We have used the molecular cytogenetic techniques of multicolor fluorescence in situ hybridization (M-FISH) and comparative genomic hybridization (CGH) to analyze two established lung cancer cell lines (A549, H520), 80 primary lung adenocarcinoma samples and 80 squamous cell lung carcinoma samples in order to identify common chromosomal aberrations. M-FISH revealed numerous complex chromosomal rearrangements. Chromosomes 5, 6, 11, 12, and 17 were most frequently involved in interchromosomal translocations. CGH revealed regions on 1q, 2p, 3q, 5p, 5q, 7p, 8q, 11q, 12q, 14q, 16p, 17p, 19q, 20q, 21q and 22q to be commonly over-represented and regions on 2q, 3p, 4p, 5q, 7q, 8p, 9p, 13q, 14q, and 17p to be under-represented. In lung adenocarcinomas the most common gains were found in 16p13 (50%); while in squamous cell lung carcinomas the common gains were found in 17q21 (45%) and these alterations were observed to be associated with their specific pathological subtype. In conclusion, the present study contributes to the molecular biological characterization in lung adenocarcinomas and squamous cell lung carcinomas and through evaluation of molecular events to the recently emergent focus on novel markers for lung cancer treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18848758     DOI: 10.1016/j.biopha.2008.08.010

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.

Authors:  Xiao-Jie Ding; Min-Xia Liu; Lei Ao; Yi-Rong Liang; Yi Cao
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

2.  A transcriptional network signature characterizes lung cancer subtypes.

Authors:  Hsun-Hsien Chang; Jonathan M Dreyfuss; Marco F Ramoni
Journal:  Cancer       Date:  2010-09-13       Impact factor: 6.860

3.  The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.

Authors:  Yushi Zhao; Ye Li; Shengfa Wang; Hongguang Lu; Jianxin Chen; Zhijie Zhang; Yubin Jin; Zhong-Zheng Zhu
Journal:  Int J Clin Oncol       Date:  2011-05-11       Impact factor: 3.402

4.  Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.

Authors:  Katja U Schneider; Dimo Dietrich; Michael Fleischhacker; Gunda Leschber; Johannes Merk; Frank Schäper; Henk R Stapert; Erik R Vossenaar; Sabine Weickmann; Volker Liebenberg; Christoph Kneip; Anke Seegebarth; Fikret Erdogan; Gudrun Rappold; Bernd Schmidt
Journal:  BMC Cancer       Date:  2011-03-22       Impact factor: 4.430

5.  Integrated analyses of copy number variations and gene expression in lung adenocarcinoma.

Authors:  Tzu-Pin Lu; Liang-Chuan Lai; Mong-Hsun Tsai; Pei-Chun Chen; Chung-Ping Hsu; Jang-Ming Lee; Chuhsing Kate Hsiao; Eric Y Chuang
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

6.  Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC.

Authors:  Federica Zito Marino; Gerardo Botti; Gabriella Aquino; Stefano Ferrero; Gabriella Gaudioso; Alessandro Palleschi; Danilo Rocco; Rosario Salvi; Maria Carolina Micheli; Pietro Micheli; Alessandro Morabito; Gaetano Rocco; Antonio Giordano; Rossella De Cecio; Renato Franco
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

7.  Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Authors:  Marianne Oulhen; Patrycja Pawlikowska; Benjamin Besse; Françoise Farace; Tala Tayoun; Marianna Garonzi; Genny Buson; Claudio Forcato; Nicolò Manaresi; Agathe Aberlenc; Laura Mezquita; Yann Lecluse; Pernelle Lavaud; Charles Naltet; David Planchard
Journal:  NPJ Precis Oncol       Date:  2021-07-16

8.  SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.

Authors:  Liang-Chuan Lai; Mong-Hsun Tsai; Pei-Chun Chen; Lee H Chen; Jen-Hao Hsiao; Shin-Kuang Chen; Tzu-Pin Lu; Jang-Ming Lee; Chung-Ping Hsu; Chuhsing K Hsiao; Eric Y Chuang
Journal:  J Biomed Sci       Date:  2014-03-21       Impact factor: 8.410

Review 9.  Prognostic factors in resected lung carcinomas.

Authors:  Keith M Kerr; Marianne C Nicolson
Journal:  EJC Suppl       Date:  2013-09

10.  Identification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing.

Authors:  Li Liu; Jiao Huang; Ke Wang; Li Li; Yangkai Li; Jingsong Yuan; Sheng Wei
Journal:  Oncotarget       Date:  2015-11-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.